Wolverine 20mg is a co-formulated research blend pairing two extensively studied synthetic peptides — BPC-157 (10mg) and TB-500 (10mg) — in a single lyophilized preparation. BPC-157 is a stable gastric pentadecapeptide derived from a body-protection compound sequence, while TB-500 is a synthetic seven-residue fragment (Ac-LKKTETQ) corresponding to residues 17–23 of Thymosin Beta-4. Supplying both in one vial gives investigators a fixed 1:1 reference material for experiments comparing the individual peptides against their combination.

In cell-culture and preclinical models, researchers use BPC-157 as a reference compound for cytoprotective and angiogenic signaling, and TB-500 for G-actin binding and cell migration. The two act through distinct but potentially complementary pathways, making this blend a convenient tool for studying combined tissue-repair mechanisms in vitro without preparing separate stock solutions.

Key research areas

  • Synergistic tissue-repair models — evaluating combined versus single-peptide effects on regeneration endpoints in cultured cells
  • Tendon, ligament, and muscle injury paradigms — in-vitro and preclinical wound and connective-tissue repair systems
  • Angiogenesis and cell migration — BPC-157-associated vascular signaling alongside TB-500-associated G-actin binding and fibroblast motility
  • Anti-inflammatory and cytoprotective pathways — screening of protective signaling cascades in stressed cell populations

Specifications

  • Composition: BPC-157 10mg + TB-500 10mg (20mg total per vial)
  • Form: Lyophilized white powder
  • Storage: Refrigerate at 2–8°C; protect from light and moisture
  • Quality: Third-party tested for identity and purity; a Certificate of Analysis is available on request

Echo Peptides supplies this blend for laboratory and in-vitro research use only. It is not for human or veterinary use and is not intended for diagnostic or therapeutic purposes.